当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析

易瑞生物

(300942)

  

流通市值:22.52亿  总市值:22.52亿
流通股本:4.05亿   总股本:4.05亿

易瑞生物(300942)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入203,098,722.74128,365,795.0957,644,102.49263,229,020.8
营业总成本234,674,152.58154,899,413.6173,515,702.11260,412,512.64
其他经营收益
营业利润-32,645,472.02-23,862,504.33-13,144,924.515,577,907.93
利润总额-33,950,837.9-24,159,286.52-13,090,611.3613,288,905.62
净利润-26,785,325.38-19,396,770.83-10,485,725.715,466,356.76
每股收益
其他综合收益-1,005,395.29-444,264.96-217,813.54160,162.48
综合收益总额-27,790,720.67-19,841,035.79-10,703,539.2415,626,519.24
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计775,093,702.41794,062,586.54798,255,225.43817,814,250.15
非流动资产:
非流动资产合计681,610,207.34686,127,769.84689,706,895.03706,733,614.44
资产总计1,456,703,909.751,480,190,356.381,487,962,120.461,524,547,864.59
流动负债:
流动负债合计103,993,553.35120,110,411.25109,458,166.26160,703,352.59
非流动负债:
非流动负债合计480,187,720.86479,633,554.94479,082,080.16456,164,030.14
负债合计584,181,274.21599,743,966.19588,540,246.42616,867,382.73
所有者权益(或股东权益):
归属于母公司股东权益合计865,790,641.09873,999,669.33893,621,562.52904,080,226.3
股东权益合计872,522,635.54880,446,390.19899,421,874.04907,680,481.86
负债和股东权益合计1,456,703,909.751,480,190,356.381,487,962,120.461,524,547,864.59
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计260,414,913.73173,305,931.8581,199,577.14344,052,768.69
经营活动现金流出小计280,233,213.29179,177,679.3893,727,023.75277,180,954.85
经营活动产生的现金流量净额-19,818,299.56-5,871,747.53-12,527,446.6166,871,813.84
投资活动产生的现金流量:
投资活动现金流入小计506,140,829.65392,094,880.16110,633,165.49866,005,376.48
投资活动现金流出小计417,279,974.4354,160,816.3782,314,399.09827,495,842.8
投资活动产生的现金流量净额88,860,855.2537,934,063.7928,318,766.438,509,533.68
筹资活动产生的现金流量:
筹资活动现金流入小计24,860,781.2824,860,781.2824,770,781.2827,328,827.62
筹资活动现金流出小计46,922,393.3229,663,339.2215,121,932.4854,846,231.04
筹资活动产生的现金流量净额-22,061,612.04-4,802,557.949,648,848.8-27,517,403.42
汇率变动对现金及现金等价物的影响-15,034,787.22-11,223,441.47-6,680,492.72986,297.22
现金及现金等价物净增加额31,946,156.4316,036,316.8518,759,675.8778,850,241.32
期末现金及现金等价物余额367,928,357.17352,018,517.59354,741,876.61335,982,200.74
补充资料:
现金及现金等价物的净增加额-16,036,316.85-78,850,241.32
TOP↑